A Randomized, Double- Blind, Placebo-Controlled, Sequential-Group Study of Multiple Doses of OAP-189 to Determine the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics When Coadministered With Metformin in Type 2 Diabetic Subject.
Phase of Trial: Phase I
Latest Information Update: 11 Aug 2011
At a glance
- Drugs Metformin; OAP 189
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
- 11 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 May 2011 Planned End Date changed from 1 Jun 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 14 Mar 2011 Planned end date changed from 1 Jan 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov.